This alert memorandum summarizes recent developments that will affect the preparation of the annual report of a foreign private issuer ("FPI") on Form 20-F for the year ended December 31, 2019 (the "Annual Report"). We have included additional details and references to sources in the endnotes.

I. CHANGES TO FORM 20-F

The U.S. Securities and Exchange Commission (the "SEC") adopted amendments in March 2019 that modernized and simplified certain requirements of Form 20-F.1 Unless otherwise noted, the following changes to Form 20-F will apply for the first time to a registrant with a December 31 fiscal year in its 2019 Annual Report, which must be filed by April 30, 2020.

Changes to Cover Page

  • Trading symbol required. The cover page now includes a field for the trading symbol for each class of securities of the company registered under Section 12 of the Securities Exchange Act of 1934 (the "Exchange Act").
  • Inline XBRL tagging. A "large accelerated filer"2 that prepares its financial statements in accordance with U.S. GAAP must tag all information on the cover page in Inline XBRL ("iXBRL"). For an FPI that prepares its financial statements in accordance with IFRS, this requirement takes effect for fiscal periods ending on or after June 15, 2021.3

Changes to MD&A (Item 5)

  • Omitting discussion of the earliest of three years. Item 5 (Operating and Financial Review and Prospects, also known as MD&A) generally requires a discussion of the three-year period covered by the financial statements included in the Annual Report. New instruction 6 to Item 5 allows a company to omit a comparison with the earliest of the three years if that discussion is included in a previous report or prospectus filed on EDGAR. We expect that a number of companies will take advantage of this instruction to present a comparison of 2019 with 2018 and not include a full comparison of 2018 with 2017.4
    • A company that takes this approach must identify the location in the prior filing where the omitted discussion may be found, but this does not require incorporating the prior filing by reference.
    • A company is still required to provide all material information in a manner that best reflects the discussion and analysis of the business as seen through the eyes of management. If a company limits MD&A comparisons to two years, it should assess whether omitting any discussion of earlier periods leaves a gap in information, and adjust MD&A disclosure accordingly.5
  • Use of any presentation format that enhances the reader's understanding. Most companies provide in their MD&A a year-to-year comparison of a number of financial statement line items. New instruction 6 to Item 5 emphasizes that a company may use any presentation that in its judgment enhances the reader's understanding of the company's financial condition, without suggesting that any one mode of presentation is preferable to another. Ideally, this clarification would encourage companies to craft improved MD&A disclosure that highlights material trends and is less mechanical.6

Changes to the Exhibits

  • Description of Registered Securities. New instruction 2(d) under Instructions as to Exhibits requires a description of all the company's securities registered under Section 12 of the Exchange Act. For each security listed, the exhibit must include information comparable to that required by the Description of Securities section in a registration statement.7
    • Disclosure from prior registration statements may be useful to prepare the new exhibit. However, a company may not satisfy the requirement by incorporating past registration statements by reference.8
      • With respect to debt securities, companies may satisfy the exhibit requirement in a variety of ways, including (i) copying the relevant disclosures from a base prospectus and prospectus supplement for each outstanding security and (ii) combining the description of various securities with similar terms into one narrative. Companies that have multiple series of debt securities listed on a U.S. exchange and thus are registered under Section 12 of the Exchange Act should consider whether combining the description of various securities makes sense to avoid a lengthy exhibit.
      • A company with longstanding registered securities may have to draft new disclosure or expand old disclosure if those securities were issued under registration statements that did not include all the disclosure required under the current form.
    • Companies can incorporate the new exhibit by reference into future annual reports so long as there has not been any change to the information required in the Description of Securities. The exhibit will need to be updated each year for any changes (including non-material changes) to the terms of the securities or to add any new securities registered under Section 12.
  • Redacting Confidential Information in Material Contract Exhibits. The amendments substantially simplify the process for redacting confidential information in agreements filed as exhibits to SEC filings. Companies can now redact confidential information from these agreements without submitting a confidential treatment request ("CTR").9
    • Only information that (i) is not material and (ii) would likely cause competitive harm to the company if publicly disclosed can be redacted from the exhibits without a CTR.10 The SEC intends to selectively review filings with redactions and may separately request the company provide an unredacted version of the document for the Staff's review.11
    • When filing a redacted exhibit, the company must (i) mark the exhibit index to indicate that portions of the exhibit have been omitted, (ii) provide a prominent statement on the first page of the redacted exhibit that certain information has been excluded and (iii) indicate by brackets (e.g., "[***]") where the information has been omitted.
    • A company that previously obtained a confidential treatment order must continue to file extension applications to protect the confidential information from public release after the original order expires.12
  • Redacting Personal Information. The amendments permit a company to redact personal confidential information if disclosure would constitute "a clearly unwarranted invasion of personal privacy" (e.g., disclosure of bank account numbers, social security numbers, home addresses and similar information). The Staff has informally permitted this for some time. These redactions will not require any further justification regarding materiality or competitive harm.13
  • Omitting Schedules from Exhibits. The amendments permit a company to omit schedules (or similar attachments) from an exhibit to a registration statement or report, unless the schedules contain material information that is not otherwise disclosed in the exhibit or in the registration statement or report.14
    • A list briefly identifying the contents of all omitted schedules must be included in the exhibit, unless such information is already included in the exhibit. We believe that a typically detailed table of contents will meet this requirement.15
    • If a company omits schedules or other attachments, it should review them to determine whether they contain information that could be material. A company must provide a copy of any omitted schedule to the SEC upon request.
  • No Look-Back Period for Material Contracts. Before the amendments, a company was required to file as exhibits all material contracts not made in the ordinary course of business if (i) the contract would be performed at or after the filing of the report or (ii) the contract was entered into less than two years prior to the filing. The amendments eliminate the second condition for a company that is not a "newly reporting registrant."16

Incorporation by Reference and Cross References

The Amendment Release included a number of revisions to Regulation S-K, Rule 411 under the Securities Act of 1933 (the "Securities Act") and Rule 12b-23 under the Exchange Act intended to streamline the requirements of incorporation by reference and facilitate investor access to incorporated documents through the use of hyperlinks.17 These revisions include:

  • Financial statements: Referencing and incorporating by reference outside information is prohibited. In the financial statements, incorporating by reference, or cross-referencing, information outside the financial statements is generally not permitted.18
  • Incorporation by reference of financial information is restricted. Financial information required to be given in comparative form for two or more periods must not be incorporated by reference unless the information incorporated by reference includes the entire period for which the comparative data is given.19
  • Copies of information incorporated by reference no longer required to be filed. Companies are no longer required to file as an exhibit copies of any information incorporated by reference.20
  • Requiring hyperlinks to information that is incorporated by reference if available on EDGAR. Companies must include active hyperlinks to information incorporated into the Annual Report by reference if the information is publicly available on EDGAR at the time the Annual Report is filed.21

Please click here to read the full alert memorandum.

Footnotes

1. The amendments, which also modified the rules and forms applicable to domestic companies, implement a statutory directive under the 2015 FAST Act, and are part of a broader "disclosure effectiveness" initiative undertaken by Congress and the SEC. FAST Act Modernization and Simplification of Regulation S-K, Release No. 33- 10618 (Mar. 20, 2019), available at https://www.sec.gov/rules/final/2019/33-10618.pdf ("Amendment Release"). See Cleary Gottlieb, SEC Simplifies Some Disclosure Requirements for Public Companies, available at https://www.clearygottlieb.com/-/media/files/alert-memos-2019/sec-simplifies-some-disclosure-requirements-for-public-companies.pdf/ ("CGSH FAST Act Memo").

2. A "large accelerated filer" is a company that (i) had an aggregate worldwide market value of common equity held by non-affiliates of $700 million or more as of the last business day of the most recently completed second fiscal quarter, (ii) has been subject to the requirements of section 13(a) or 15(d) of the Exchange Act for a period of at least twelve calendar months, and (iii) has filed at least one annual report pursuant to section 13(a) or 15(d) of the Exchange Act. 17 CFR § 240.12b-2(2).

3. The new cover page iXBRL tagging requirement has the same phase-in period as the iXBRL requirement for financial information discussed under "Other New Requirements—iXBRL for Financial Information." See Instruction 104 of the "Instructions as to Exhibits" and Rule 406 of Regulation S-T (17 C.F.R. § 232.406).

4. A survey by The Corporate Counsel found, however, that of 79 Form 10-K filings by large accelerated filers between May 3 and July 15, 2019, only 17 companies omitted the discussion of the earliest year in their filing. The Corporate Counsel, Early Returns From the Fast Act Rule Changes (July-August 2019). The opportunity to omit the discussion of the earliest year might be especially attractive to dual-listed FPIs that are not required to include that earlier year of financial information in their home country filings.

5. For example, revisions to the earliest year information as a result of a restatement or the retrospective adoption of a new accounting principle, or evidence of a three-year trend, might be sufficiently material to warrant discussion. See CGSH FAST Act Memo.

6. See CGSH FAST Act Memo; Amendment Release p. 15.

7. More precisely, the description must include information comparable to that required by Items9.A.3, A.5, A.6, and A.7, Items10.B.3, B.4, B.6, B.7, B.8, B.9, and B.10, and Items12.A, 12.B, 12.C, and 12.D.1 and 12.D.2 of Form 20-F (collectively, the "Description of Securities").

8. See Instruction 2(d) in the "Instructions as to Exhibits" and Amendment Release p. 60 (acknowledging that the information in the exhibit will overlap with disclosure in publicly available registration statements, but that providing all the information in one location is better than requiring investors to piece together the information from multiple documents).

9. See Instruction 4(a) in the "Instructions as to Exhibits." A company may withdraw any pending CTRs and amend their filing to conform to the new rule requirement.

10. Instruction 4(a) in the "Instructions as to Exhibits" in Form 20-F specifically refers to the materiality and competitive harm prongs. Subsequent to the adoption of the amendments, the Supreme Court eliminated the competitive harm prong under exemption 4 of the Freedom of Information Act (5 U.S.C. § 552(b)(4)) ("FOIA Exemption 4"). Food Marketing Institute v. Argus Leader Media, 139 S.Ct. 2356 (2019). As a result, a regular CTR that relies on FOIA Exemption 4 may provide a more lenient legal standard to protect confidential information (but procedurally, it would be substantially more burdensome than the procedures set forth by the amendments).

11. The SEC staff (the "Staff") has stated that companies should be mindful of how they respond to such requests and only send the unredacted version of the document back to the Staff in the manner requested in the correspondence (i.e., by mail to the address provided). If after reviewing the unredacted version the Staff has questions regarding materiality or competitive harm, the Staff may request the company provide a materiality and competitive harm analysis. The Staff will provide these requests under a separate chain of comments from the regular comment review process to minimize the risk of inadvertent public disclosure of competitive information. Staff Guidance, New Rules and Procedures for Exhibits Containing Immaterial, Competitively Harmful Information (April 1, 2019), available at https://www.sec.gov/corpfin/announcement/new-rules-and-procedures-exhibits-containing-immaterial.

12. Refiling a redacted exhibit that was covered by a previously approved CTR in the manner specified by the amendments will not provide confidential treatment. SEC, New Streamlined Procedure for Confidential Treatment Extensions(April 16, 2019), available at https://www.sec.gov/corpfin/streamlined-procedure-confidential-treatment-extensions. To facilitate and streamline the CTR extension process, the SEC developed a 1-page extension application (available at https://www.sec.gov/divisions/corpfin/short-form-extension-requests.pdf).

13. See introductory text of the "Instructions as to Exhibits" in Form 20-F.

14. For example, a company that files a joint venture agreement as an exhibit to Form 20-F may omit from the exhibit any form agreements that are included as schedules to the joint venture agreement.

15. See CGSH FAST Act Memo.

16. See Instruction 4(a) in the Instructions as to Exhibits in Form 20-F. A "newly reporting registrant" would include, for example, a company that is filing its first registration statement under the Securities Act or the Exchange Act, or a SPAC that completes an acquisition that causes it to cease being a shell company.

17. Instruction to Item 19 in Form 20-F references Rule 12b-23 regarding incorporation by reference. The amendments rescind Rule 12b-32, which explained the circumstances in which a company may incorporate exhibits by reference (Rule 12b- 23(c) now sets forth those circumstances).

18. Rule 12b-23(b). This avoids confusion about which financial information has been audited or reviewed by the independent auditor. Amendment Release at note 86 and accompanying text.

19. Rule 12b-23(b).

20. The amendments rescinded rule 12b-23(a)(3), which contained this requirement.

21. Rule 12b-23(d).

To view original article, please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.